NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00003893,Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer,https://clinicaltrials.gov/study/NCT00003893,,COMPLETED,"RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumors cells. Combining chemotherapy with radiation therapy may kill more tumor cells. It is not yet known which regimen of chemotherapy plus radiation therapy is more effective for early-stage breast cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of two different regimens of adjuvant chemotherapy plus radiation therapy in treating women who have early-stage breast cancer.",NO,Breast Cancer,DRUG: CMF regimen|DRUG: cyclophosphamide|DRUG: doxorubicin hydrochloride|DRUG: epirubicin hydrochloride|DRUG: fluorouracil|DRUG: methotrexate|DRUG: mitomycin C|DRUG: mitoxantrone hydrochloride|PROCEDURE: adjuvant therapy|RADIATION: radiation therapy,,,,University Hospital Birmingham,,FEMALE,"CHILD, ADULT, OLDER_ADULT",PHASE3,2250,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,CDR0000067062|CRC-TU-BR3015|EU-99005,1998-07,,2006-04,2003-01-27,,2013-12-19,"Queen Elizabeth Hospital at University of Birmingham, Birmingham, England, B15 2TH, United Kingdom",
